Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.60
+0.57 (2.28%)
Oct 19, 2026, 10:22 AM EDT - Market open
Zymeworks Employees
Zymeworks had 231 employees as of June 30, 2026. The number of employees decreased by 42 or -15.38% compared to the same quarter last year. That makes Zymeworks the 25,754th largest employer in the world and 3,285th in the United States.
Employees
231
Change
-42
Growth
-15.38%
Revenue / Employee
$160,723
Profits / Employee
-$649,316
Market Cap
1.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 231 | -42 | -15.38% | 231 | 0 |
| Mar 31, 2026 | 243 | -56 | -18.73% | 243 | 0 |
| Dec 31, 2025 | 264 | -22 | -7.69% | 264 | 0 |
| Sep 30, 2025 | 263 | -31 | -10.54% | 263 | 0 |
| Jun 30, 2025 | 273 | -17 | -5.86% | 273 | 0 |
| Mar 31, 2025 | 299 | 24 | 8.73% | 299 | 0 |
| Dec 31, 2024 | 286 | 8 | 2.88% | 280 | 6 |
| Sep 30, 2024 | 294 | 42 | 16.67% | 294 | 0 |
| Jun 30, 2024 | 290 | 53 | 22.36% | 290 | 0 |
| Mar 31, 2024 | 275 | -29 | -9.54% | 275 | 0 |
| Dec 31, 2023 | 278 | -16 | -5.44% | 272 | 6 |
| Sep 30, 2023 | 252 | -34 | -11.89% | 252 | 0 |
| Jun 30, 2023 | 237 | -47 | -16.55% | 237 | 0 |
| Mar 31, 2023 | 304 | -23 | -7.03% | 304 | 0 |
| Dec 31, 2022 | 294 | -164 | -35.81% | 291 | 3 |
| Sep 30, 2022 | 286 | -169 | -37.14% | 286 | 0 |
| Jun 30, 2022 | 284 | -141 | -33.18% | 284 | 0 |
| Mar 31, 2022 | 327 | -56 | -14.62% | 327 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Novavax | 749 |
| Agios Pharmaceuticals | 540 |
| Maravai LifeSciences Holdings | 415 |
| UroGen Pharma | 300 |
| Xencor | 260 |
| Septerna | 123 |
| Mesoblast | 108 |
ZYME News
- 4 hours ago - Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma - GlobeNewsWire
- 3 days ago - Zymeworks Proxy statement: Proxy filing - Filings
- 4 days ago - Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results - GlobeNewsWire
- 12 days ago - Zymeworks price target raised to $34 from $32 at Truist - TheFly
- 20 days ago - Zymeworks reinstated with a Buy at TD Cowen - TheFly
- 20 days ago - Zymeworks price target raised to $39 from $38 at Citi - TheFly
- 20 days ago - LifeSci flags Yupelri as a key growth driver after Zymeworks’ Theravance deal - TheFly
- 21 days ago - Zymeworks Transcript: M&A announcement - Transcripts